References
1. Pleiotropic Effects of Statins: Lipid Reduction and Beyond | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic [Internet]. [cited 2022 Mar 1]. Available from: https://academic.oup.com/jcem/article/87/4/1451/2374926
2. Pasternak RC, Smith SC, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002 Aug 7;40(3):567–72.
3. Deren ME, Klinge SA, Mukand NH, Mukand JA. Tendinopathy and Tendon Rupture Associated with Statins. JBJS Rev. 2016 May 17;4(5):e4.
4. Pleiotropic Effects of Statins | IntechOpen [Internet]. [cited 2022 Mar 1]. Available from: https://www.intechopen.com/chapters/47562
5. Basiak M, Kosowski M, Cyrnek M, Bułdak Ł, Maligłówka M, Machnik G, et al. Pleiotropic Effects of PCSK-9 Inhibitors. Int J Mol Sci. 2021 Mar 19;22(6):3144.
6. Gallego-Colon E, Daum A, Yosefy C. Statins and PCSK9 inhibitors: A new lipid-lowering therapy. Eur J Pharmacol. 2020 Jul 5;878:173114.
7. Allahyari A, Jernberg T, Hagström E, Leosdottir M, Lundman P, Ueda P. Application of the 2019 ESC/EAS dyslipidemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study. Eur Heart J. 2020 Oct 21;41(40):3900–9.